The 2017 Annual Meeting of the American Society of Oncology (ASCO) will be held in Chicago on June 2, local time. At 12 noon on May 17, local time, ASCO held a pre-meeting press conference at Alexandria headquarters to announce the LBA research release and report Schedule.
Professor Wu Yilong’s research (Abstract 8500)
Professor Hayes, Chairman of ASCO, and Professor Johnson, Chairman of Hou Ren, introduced and recommended 6 studies, among which were among them. The following is the main content of one of the six studies ABSTRACT 3517.
The study used CALGB’s questionnaire of 826 patients in the phase III colorectal cancer clinical trial in 1999 to analyze the relationship between eating nuts and the risk of colon cancer recurrence and death.The specific test results of the study will be reported at the ASCO 2017 meeting (ABSTRACT 3517).
Main results
More than 2 ounces
The results of this observational study showed that patients with colon cancer who consumed nuts for one week compared with patients who did not consume nuts,
The benefit from edible nuts has nothing to do with known prognostic factors (age, BMI, gender, common genetic mutations), etc.
Woody nuts include almonds, walnuts, hazelnuts, cashews, and walnuts.
The second analysis of the study showed that the nuts that benefited colon cancer patients were limited to woody nuts (tree nuts).
Comment
ASCO Chairman Daniel F. Hayes: “Healthy diets during cancer treatment are often easily overlooked. This study shows that things like nuts can also affect the outcome of cancer patients. Hopefully, in the future of colorectal cancer diagnosis and treatment When clinicians decide on disease treatment strategies, healthy dietary factors should also be taken into account. “
Researcher Professor Temidayo pointed out at the press conference: “A number of studies have shown that people with heart disease and diabetes can benefit from taking nuts. We think it is necessary to carry out this trial in cancer patients.
“For advanced patients, the question often asked by doctors is what can they reduce the risk of disease recurrence and death in addition to standard treatment. The concept of benefit from healthy diet and physical exercise advocated by the study is this A blank makes an effective addition. “
Patients with stage III colorectal cancer have a 3-year survival rate of 70% after surgery, radiotherapy and chemotherapy. Many studies have shown that diet is important for cancer prevention, so we have the idea of conducting this clinical trial.
